AIHealthcare

Artera AI (formerly CureMetrix in the oncology AI space) is a precision medicine company that develops **AI-powered tools for personalized cancer management**, using a multi‑modal artificial intelligence platform that analyzes digital pathology and clinical data to help guide treatment decisions and improve outcomes for oncology patients. Publicly available information indicates Artera AI focuses on **oncology decision support and biomarker discovery**, but detailed corporate data (funding, leadership, and full corporate history) is not comprehensively disclosed in the sources available and much of its legacy information under the CureMetrix brand is not visible in current search results.